Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
861,370
-
Shares change
-
-1,669,824
-
Total reported value, excl. options
-
$62,932,502
-
Value change
-
-$121,700,494
-
Put/Call ratio
-
176%
-
Number of buys
-
22
-
Number of sells
-
-14
-
Price
-
$73.07
Significant Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q2 2021
61 filings reported holding PPH - VANECK ETF TRUST - PHARMACEUTCL ETF as of Q2 2021.
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 861,370 shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (165,348 shares), GOLDMAN SACHS GROUP INC (147,127 shares), 20/20 Capital Management, Inc. (127,911 shares), CITADEL ADVISORS LLC (65,028 shares), Orion Portfolio Solutions, LLC (58,083 shares), MORGAN STANLEY (57,668 shares), OSAIC HOLDINGS, INC. (34,077 shares), Tower Research Capital LLC (TRC) (29,680 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (24,037 shares), and LPL Financial LLC (16,180 shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.